Clinical trial · Interventional
Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy
Feasibility of Monitoring Step Count as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Patients Undergoing Radiation Therapy
NCT04186832CI-TRIAL-00121357active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trial studies the feasibility of monitoring step count as a measure of physical activity in patients with newly diagnosed glioma undergoing radiation therapy. Physical activity measured by step count may help to improve the quality of life and symptoms for patients with newly diagnosed glioma.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glioma | Glioma | ONTOLOGY_EXACT | 0.98 |
| Radiation Therapy Patient | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| FitBit | Device | — | UNRESOLVED |
| Pedometer | Device | — | UNRESOLVED |
| Quality-of-Life Assessment | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Group I (pedometer)
- description
- Patients wear a pedometer for step count monitoring over 6 weeks.
- interventionNames
- Device: Pedometer
- Other: Quality-of-Life Assessment
- Other: Questionnaire Administration
- type
- EXPERIMENTAL
- label
- Group II (FitBit)
- description
- Patients wear a FitBit for step count monitoring over 6 weeks.
- interventionNames
- Device: FitBit
- Other: Quality-of-Life Assessment
- Other: Questionnaire Administration
Primary outcomes (4)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed with a glioma and going to receive at least 4 weeks of RT at MDACC at the Texas Medical Center campus with at least 20 fractions * Karnofsky performance status (KPS) of 70 or above * Wearable activity tracker (WAT) - naive * Able to read and speak English * Able to provide informed consent * Access to a smartphone * Access to Wi-Fi Exclusion Criteria: * Cognitive and/or major sensory deficits that would impede the completion of assessment instruments as deemed by the clinical team
References
Publications (0)
Data not yet available
No reference posted for this study.